Nawar T, Nolin L, Plante G E, Caron C, Montambault P
Can Med Assoc J. 1977 Nov 19;117(10):1178-82.
Minoxidil, a new potent hypotensive agent, was used as the primary antihypertensive agent in 11 patients--10 men and 1 woman aged 35 to 54 years with severe hypertension that was refractory to treatment with maximal (or maximally tolerated) doses of conventional antihypertensive agents. Six patients had severely impaired renal function and three of them were undergoing long-term hemodialysis. The patients were given 2.5 to 40 mg/d of minoxidil for periods of 2 to 29 months. All except one who was almost anuric received propranolol and diuretics. Blood pressure was controlled satisfactorily in all patients. In two patients the hypertension became partially resistant after 1 year of treatment. The main side effects were sodium retention, tachycardia and hirsutism. Renal function remained stable or improved and hemodialysis was discontinued in two patients. Minoxidil is a remarkably potent hypotensive with relatively few side effects and seems particularly advantageous in patients with chronic renal failure.
米诺地尔是一种新型强效降压药,在11例患者中用作主要降压药,其中10名男性和1名女性,年龄在35至54岁之间,患有严重高血压,使用最大(或最大耐受)剂量的传统降压药治疗无效。6例患者肾功能严重受损,其中3例正在接受长期血液透析。患者服用2.5至40毫克/天的米诺地尔,疗程为2至29个月。除1例几乎无尿的患者外,所有患者均接受了普萘洛尔和利尿剂治疗。所有患者的血压均得到满意控制。2例患者在治疗1年后高血压出现部分抵抗。主要副作用是钠潴留、心动过速和多毛症。肾功能保持稳定或改善,2例患者停止了血液透析。米诺地尔是一种非常有效的降压药,副作用相对较少,在慢性肾衰竭患者中似乎特别有利。